Explore the BIO Digital 2021 Sessions below. Check back often, sessions will be scheduled soon, with more announced in the coming weeks!
Reliable and in-depth business development intelligence is critical to sustaining biopharma…
One Health, or the concept that animal, human, and environmental health are interconnected, has…
The COVID-19 pandemic has highlighted the critical public health role for rapid, accurate and…
We have been starkly reminded that infectious disease pandemics are very costly to society - but…
Infectious diseases like to travel and they often do so incognito with no passports required,…
In the current environment, nascent biotech companies can raise funding from a variety of…
Data and evidence are nice, but in the post-media era of alternative facts, they may not matter…
With a 175% increase in announced SPAC M&As for biopharma deals between 2019 and 2020, it…
As the COVID‐19 pandemic initially emerged, the narrative was that children were spared and that…
The onset of the COVID-19 pandemic required rapid development and availability of potential…
Vaccines have gone from under the radar to everywhere in the mind of the public and many new…
IPOs and after-market performance have continued at a breakneck pace. The influx of investor…
Patients, policymakers, and payors continue to look toward health technology assessment (HTA) as…
The conduct of clinical trials has been evolving as a result of new technologies and tools and…
Dealmakers adjusted to the new landscape of remote work and navigating a global health…
The pandemic forced support ecosystems for emerging biotechs to adapt their processes to…
An interactive and practical program focusing on the ongoing impact of the pandemic on corporate…
Commercialization was once considered the last mile for any digital medicine company or…
The IPO Class has grown over the last 8 years and continued through a COVID-19 inflection. This…
The COVID-19 pandemic has exposed vulnerabilities and inequities throughout society, including…
Innovative collaborations increasingly play a vital role in ensuring that the latest scientific…
Gene therapies are transforming patients’ lives in ways unimaginable 20 years ago&mdash…
What we eat and how we access food is transforming and investment trends in food and ag tech…
Persons living with a rare disease or condition and their caregivers face unique, time-consuming…
Patients are more involved in their healthcare decision-making today than ever before, and are…
For over a decade now, the patient’s journey through the healthcare system has been…
This event brings together thought leaders from the across the biotechnology ecosystem to share…
BIO, in partnership with Coqual, is launching the second-annual Measuring Diversity and…
In the era of COVID, research in vaccines and diagnostics aimed at stopping the spread of…
In an age of crisis, can the biopharma industry withstand global shocks?
2020 revealed…
Companies, investors, and shareholders have business imperatives to ensure boards reflect the…
Current Federal and State reimbursement systems are not nimble enough to accommodate the pace of…
One of the pillars of the BIOEquality Agenda is expanding opportunities in the industry for…
The U.S. biotechnology industry has weathered several economic downturns but the COVID pandemic…
In this panel, learn ways to accelerate post-discovery to IND milestone timelines leading to…
The COVID-19 pandemic and scientific and technological advancements have made modern approaches…
